Advair reprieve gives GSK breathing spaceGlaxoSmithKline looks set to have another year without US generic competition to its respiratory blockbuster Advair, after the Share XAdvair reprieve gives GSK breathing spacehttps://pharmaphorum.com/news/advair-reprieve-gives-gsk-breathing-space/
GSK’s new pharma chief Miels to join in SeptemberLuke Miels to start role after GSK and AZ end contract row. Share XGSK’s new pharma chief Miels to join in Septemberhttps://pharmaphorum.com/news/gsks-new-pharma-chief-join-september/